Summary

The Asia-Pacific veterinary diagnostics market is expected to reach USD 3.19 billion by 2032 from USD 1.70 billion in 2024, growing at a substantial CAGR of 8.3% in the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Veterinary Diagnostics Market, By Type (Reagents & Consumables and Instruments & Devices), Technology (Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Clinical Biochemistry, Imaging, and Others), Animal Type (Companion Animals and Livestock Animals), Disease Type (Infectious Diseases, Non-Infectious Diseases, Hereditary, and Others), Species (Canine, Feline, Porcine, Avian, Bovine, Equine, Ovine & Caprine (Combined), Camelid, and Others), Testing Location (Laboratory-Based Testing and Point-of-Care Testing (POCT)), End User (Veterinary Hospitals, Veterinary Clinics, Animal Farms and Husbandry, Animal Diagnostic Laboratories, Academic and Research Laboratories, Pet Shops, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, New Zealand, Cambodia, Myanmar, Vietnam, and rest of Asia-Pacific) - Industry Trends & Forecast To 2032
Overview of the Asia-Pacific Veterinary Diagnostics Market Dynamics:
Drivers
• Increase in animal health awareness
• Continuous advancements in veterinary diagnostic technologies
Restraint
• High cost of advanced diagnostic technologies
Opportunity
• Mobile diagnostic vans for rural livestock testing
• Increased pet ownership driving higher spending patterns
Market Players:
The key market players for Asia-Pacific veterinary diagnostics market are listed below:
• FUJIFILM Holdings Corporation (Japan)
• PLANMECA OY (Finland)
• Eiken Chemical Co., Ltd. (Japan)
• Bio-Rad Laboratories, Inc. (U.S.)
• ESAOTE SPA (Italy)
• Randox Laboratories Ltd. (U.K.)
• Sysmex Corporation (Japan)
• Nova Biomedical (U.S.)
• IDEXX Laboratories, Inc (U.S.)
• Antech Diagnostics, Inc (U.S.)
• Virbac (France)
• Zoetis Services LLC (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Hangzhou Antigenne Technology Co., Ltd. (China)
• VMRD, Inc. (U.S.)
• Innovative Diagnostics (France)
• QIAGEN (Netherlands)
• Ring Biotechnology Co Ltd. (China)
• Meridian Bioscience, Inc. (U.S.)
• VetDiag Genomix Pvt Ltd (India)
• Alvedia (France)
• Narang Medical Limited (India)
• KH Medical (South Korea)
• Agrolabo S.p.A. (Italy)
• HiMedia Laboratories (India)
• AdvaCare Pharma (U.S.)
• Bionote USA Inc. (South Korea)
• URIT MEDICAL ELECTRONIC CO., LTD. (China)
• Gold Standard Diagnostics (Hungary)
• BIOMÉRIEUX (France)
• Neogen Corporation (U.S.)
• Mylab Discovery Solutions Pvt. Ltd. (India)
• Shenzhen Mindray Animal Medical Technology Co., LTD. (China)
• SKYLA CORPORATION (Taiwan)

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 56
1.1 OBJECTIVES OF THE STUDY 56
1.2 MARKET DEFINITION 56
1.3 OVERVIEW OF THE ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET 56
1.4 LIMITATIONS 58
1.5 MARKETS COVERED 59
2 MARKET SEGMENTATION 64
2.1 MARKETS COVERED 64
2.2 GEOGRAPHICAL SCOPE 65
2.3 YEARS CONSIDERED FOR THE STUDY 65
2.4 CURRENCY AND PRICING 65
2.5 DBMR TRIPOD DATA VALIDATION MODEL 66
2.6 MULTIVARIATE MODELLING 69
2.7 TYPE LIFELINE CURVE 70
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 71
2.9 DBMR MARKET POSITION GRID 72
2.10 VENDOR SHARE ANALYSIS 73
2.11 MARKET END USER COVERAGE GRID 74
2.12 SECONDARY SOURCES 75
2.13 ASSUMPTIONS 75
3 EXECUTIVE SUMMARY 76
4 PREMIUM INSIGHTS 80
4.1 PESTAL ANALYSIS 82
4.2 PORTERS FIVE FORCES ANALYSIS 83
4.3 MICRO AND MACRO ECONOMIC FACTORS 84
4.4 PENETRATION AND GROWTH PROSPECT MAPPING 84
4.5 COST ANALYSIS BREAKDOWN 84
4.6 TECHNOLOGY ROADMAP 85
4.7 REIMBURSEMENT FRAMEWORK 85
4.8 OPPUTUNITY MAP ANALYSIS 86
4.9 VALUE CHAIN ANALYSIS 86
4.10 HEALTHCARE ECONOMY 86
4.11 TARIFF 89
4.11.1 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE 89
4.11.2 VENDOR SELECTION CRITERIA DYNAMICS 89
4.11.3 IMPACT ON SUPPLY CHAIN 89
4.11.3.1 RAW MATERIAL PROCUREMENT 89
4.11.3.2 MANUFACTURING AND PRODUCTION 89
4.11.3.3 LOGISTICS AND DISTRIBUTION 89
4.11.3.4 PRICE PITCHING AND MARKET POSITION 89
4.11.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 90
4.11.4.1 SUPPLY CHAIN OPTIMIZATION 90
4.11.4.2 JOINT VENTURE ESTABLISHMENTS 90
4.11.5 IMPACT ON PRICES 90
4.11.6 REGULATORY INCLINATION 90
4.11.6.1 GEOPOLITICAL SITUATION 90
4.11.6.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 90
4.11.6.2.1 FREE TRADE AGREEMENTS 90
4.11.6.2.2 ALLIANCE ESTABLISHMENTS 90
4.11.6.3 STATUS ACCREDITATION (INCLUDING MFTN) 90
4.11.6.4 DOMESTIC COURSE OF CORRECTION 90
4.11.6.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 90
4.11.6.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 90
4.11.7 PRICE INDEX 91
4.12 REGULATORY FRAMEWORK 92
5 MARKET OVERVIEW 95
5.1 DRIVERS 97
5.1.1 INCREASE IN ANIMAL HEALTH AWARENESS 97
5.1.2 CONTINUOUS ADVANCEMENTS IN VETERINARY DIAGNOSTIC TECHNOLOGIES 98
5.1.3 NEWER LAUNCHES IN THE VETERINARY DIAGNOSTICS SEGMENT 99
5.1.4 REGULATORY SUPPORT AND APPROVALS ASSOCIATED WITH THE DIAGNOSTICS 100
5.2 RESTRAINTS 101
5.2.1 HIGH COST OF ADVANCED DIAGNOSTIC TECHNOLOGIES 101
5.2.2 LACK OF TRAINED PROFESSIONALS 102
5.3 OPPORTUNITIES 103
5.3.1 MOBILE DIAGNOSTIC VANS FOR RURAL LIVESTOCK TESTING 103
5.3.2 INCREASED PET OWNERSHIP DRIVING HIGHER SPENDING PATTERNS 104
5.3.3 CUSTOMIZED VETERINARY DIAGNOSTIC SOLUTIONS 107
5.4 CHALLENGES 108
5.4.1 LIMITED AWARENESS AMONG LIVESTOCK AND PET OWNERS 108
5.4.2 INADEQUATE INFRASTRUCTURE AND LOGISTICS HINDER VETERINARY DIAGNOSTICS PROGRESS 109
 
6 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY TYPE 110
6.1 OVERVIEW 111
6.2 REAGENTS & CONSUMABLES 114
6.2.1 KITS 115
6.2.1.1 PCR KITS 115
6.2.1.2 RAPID TEST KITS 115
6.2.1.3 MULTIPLEX KITS 115
6.2.1.4 ELISA KITS 115
6.2.1.5 SAMPLE PREPARATION KITS ISOLATION AND EXTRACTION KITS 115
6.2.1.6 OTHERS 115
6.2.2 REAGENTS 116
6.2.2.1 NUCLEIC ACID EXTRACTION REAGENTS 116
6.2.2.2 IMMUNOFLUORESCENCE REAGENTS 116
6.2.2.2.1 INDIRECT IMMUNOFLUORESCENCE 116
6.2.2.2.2 DIRECT IMMUNOFLUORESCENCE 116
6.2.2.3 COOMBS REAGENTS 117
6.2.2.4 OTHERS REAGENTS 117
6.2.3 MEDIA 117
6.2.4 PANEL 117
6.2.5 STRIPS 117
6.2.6 CASSETTE 117
6.2.7 CONTROL STANDARDS 117
6.2.8 PROBES AND PRIMER 117
6.2.9 OTHERS CONSUMABLE AND ACCESSORIES 117
6.3 INSTRUMENTS & DEVICES 117
6.3.1 HEMATOLOGY ANALYZERS 118
6.3.1.1 AUTOMATIC 118
6.3.1.2 SEMI-AUTOMATIC 118
6.3.1.2.1 STANDARD PRICE RANGE 118
6.3.1.2.2 HIGH PRICE RANGE 119
6.3.1.2.2.1 BENCHTOP 119
6.3.1.2.2.2 PORTABLE 119
6.3.2 CHEMISTRY ANALYZERS 119
6.3.2.1 AUTOMATIC 119
6.3.2.2 SEMI-AUTOMATIC 120
6.3.2.2.1 BENCHTOP 120
6.3.2.2.2 PORTABLE 120
6.3.2.2.2.1 BLOOD 120
6.3.2.2.2.2 URINE 120
6.3.2.2.2.3 STOOL 120
6.3.2.2.2.4 OTHERS 120
6.3.3 POINT-OF-CARE INSTRUMENTS 121
6.3.3.1 LATERAL FLOW POCT 121
6.3.3.2 MOLECULAR POCT 121
6.3.3.3 OTHERS 121
6.3.4 COAGULATION ANALYZERS 121
6.3.4.1 AUTOMATIC 121
6.3.4.2 SEMI-AUTOMATIC 122
6.3.4.2.1 4-CHANNEL 122
6.3.4.2.2 1-CHANNEL 122
6.3.4.2.2.1 WHOLE BLOOD 122
6.3.4.2.2.2 PLASMA 123
6.3.4.2.2.2.1 BENCHTOP 123
6.3.4.2.2.2.2 PORTABLE 123
6.3.5 URINALYSIS EQUIPMENT 123
6.3.5.1 AUTOMATIC 123
6.3.5.2 SEMI-AUTOMATIC 123
6.3.6 REFRACTOMETER 124
6.3.6.1 OPTICAL 124
6.3.6.2 DIGITAL 124
6.3.6.2.1 BENCHTOP 124
6.3.6.2.2 PORTABLE 124
6.3.7 OTHERS 125
6.3.7.1 AUTOMATIC 125
6.3.7.2 SEMI-AUTOMATIC 125
6.3.7.2.1 BENCHTOP 125
6.3.7.2.2 PORTABLE 125
7 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE 126
7.1 OVERVIEW 127
7.2 COMPANION ANIMALS 130
7.2.1 DOGS 130
7.2.2 CATS 130
7.2.3 HORSES 130
7.2.4 OTHERS 130
7.3 LIVESTOCK ANIMALS 131
7.3.1 POULTRY 131
7.3.2 CATTLE 131
7.3.3 SWINE 131
7.3.4 OTHERS 131
 
8 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY TESTING LOCATION 132
8.1 OVERVIEW 133
8.2 LABORATORY-BASED TESTING 136
8.3 POINT-OF-CARE TESTING (POCT) 136
9 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY SPECIES 137
9.1 OVERVIEW 138
9.2 CANINE 141
9.3 FELINE 141
9.4 PORCINE 141
9.5 AVIAN 141
9.6 BOVINE 141
9.7 EQUINE 141
9.8 OVINE & CAPRINE (COMBINED) 141
9.9 CAMELID 142
9.10 OTHERS 142
10 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 143
10.1 OVERVIEW 144
10.2 DIRECT TENDER 147
10.3 RETAIL SALES 147
10.3.1 OFFLINE 147
10.3.2 ONLINE 147
10.4 OTHERS 147
11 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY 148
11.1 OVERVIEW 149
11.2 IMMUNODIAGNOSTICS 152
11.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA) 152
11.2.2 RADIOIMMUNOASSAY 152
11.2.3 IMMUNOFLUORESCENCE 152
11.2.4 OTHERS 152
11.2.4.1 COMPANION ANIMALS 153
11.2.4.2 LIVESTOCK ANIMALS 153
11.3 MOLECULAR DIAGNOSTICS 153
11.3.1 POLYMERASE CHAIN REACTION (PCR) 153
11.3.1.1 QPCR 154
11.3.1.2 RT-PCR 154
11.3.1.3 MULTIPLEX PCR 154
11.3.1.4 SPCR 154
11.3.1.5 OTHERS 154
11.3.2 DNA SEQUENCING 154
11.3.2.1 NEXT-GENERATION SEQUENCING (NGS) 154
11.3.2.2 SANGER SEQUENCING 154
11.3.2.3 FRAGMENT SEQUENCING 154
11.3.2.4 OTHERS 154
11.3.3 MICROARRAY 155
11.3.4 OTHERS 155
11.3.4.1 COMPANION ANIMALS 155
11.3.4.2 LIVESTOCK ANIMALS 155
11.4 HEMATOLOGY 155
11.4.1 COMPANION ANIMALS 155
11.4.2 LIVESTOCK ANIMALS 155
11.5 URINALYSIS 156
11.5.1 COMPANION ANIMALS 156
11.5.2 LIVESTOCK ANIMALS 156
11.6 CLINICAL BIOCHEMISTRY 156
11.6.1 COMPANION ANIMALS 156
11.6.2 LIVESTOCK ANIMALS 156
11.7 IMAGING 157
11.7.1 COMPANION ANIMALS 157
11.7.2 LIVESTOCK ANIMALS 157
11.8 OTHERS 157
11.8.1 COMPANION ANIMALS 157
11.8.2 LIVESTOCK ANIMALS 157
12 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY DISEASE TYPE 158
12.1 OVERVIEW 159
12.2 INFECTIOUS DISEASES 162
12.2.1 BACTERIAL 162
12.2.1.1 CANINE PYOMETRA 162
12.2.1.2 ACTINOBACILLOSIS 162
12.2.1.3 ACTINOMYCOSIS 163
12.2.1.4 OTHERS 163
12.2.2 VIRAL 163
12.2.2.1 CANINE PARVOVIRUS 163
12.2.2.2 BOVINE VIRAL DIARRHEA (BVD) 163
12.2.2.3 OTHERS 163
12.2.3 FUNGAL 163
12.2.3.1 RINGWORM 164
12.2.3.2 CRYPTOCOCCOSIS 164
12.2.3.3 OTHERS 164
12.2.4 OTHERS 164
12.3 NON-INFECTIOUS DISEASES 164
12.3.1 DIABETES MELLITUS 164
12.3.2 CUSHING'S DISEASE 164
12.3.3 RENAL (KIDNEY) DISEASE 164
12.3.4 OTHERS 164
12.4 HEREDITARY 165
12.4.1 CANCER 165
12.4.2 HEART DISEASE 165
12.4.3 SKIN COMPLAINTS 165
12.4.4 HIP DYSPLASIA 165
12.4.5 EPILEPSY 165
12.4.6 OTHERS 165
12.5 OTHERS 165
13 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY END USER 166
13.1 OVERVIEW 167
13.2 VETERINARY HOSPITALS 170
13.2.1 REAGENTS & CONSUMABLES 170
13.2.2 INSTRUMENTS & DEVICES 170
13.3 VETERINARY CLINICS 171
13.3.1 REAGENTS & CONSUMABLES 171
13.3.2 INSTRUMENTS & DEVICES 171
13.4 ANIMAL FARMS AND HUSBANDRY 172
13.4.1 REAGENTS & CONSUMABLES 172
13.4.2 INSTRUMENTS & DEVICES 172
13.5 ANIMAL DIAGNOSTIC LABORATORIES 173
13.5.1 REAGENTS & CONSUMABLES 173
13.5.2 INSTRUMENTS & DEVICES 173
13.6 ACADEMIC AND RESEARCH INSTITUTE 174
13.6.1 REAGENTS & CONSUMABLES 174
13.6.2 INSTRUMENTS & DEVICES 174
13.7 PET SHOPS 175
13.7.1 REAGENTS & CONSUMABLES 175
13.7.2 INSTRUMENTS & DEVICES 175
13.8 OTHERS 175
13.8.1 REAGENTS & CONSUMABLES 175
13.8.2 INSTRUMENTS & DEVICES 175
 
14 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET, BY COUNTRY 176
14.1 ASIA-PACIFIC 176
14.1.1 JAPAN 179
14.1.2 INDIA 198
14.1.3 AUSTRALIA 216
14.1.4 SOUTH KOREA 234
14.1.5 THAILAND 252
14.1.6 INDONESIA 270
14.1.7 MALAYSIA 288
14.1.8 SINGAPORE 306
14.1.9 NEW ZEALAND 324
14.1.10 PHILIPPINES 342
14.1.11 VIETNAM 360
14.1.12 CAMBODIA 378
14.1.13 MYANMAR 396
14.1.14 REST OF ASIA-PACIFIC 414
15 ASIA-PACIFIC VETERINARY DIAGNOSTICS MARKET: COMPANY LANDSCAPE 415
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 415
16 SWOT ANALYSIS 416
16.1 IDEXX LABORATORIES, INC 417
16.1.1 COMPANY SNAPSHOT 417
16.1.2 REVENUE ANALYSIS 417
16.1.3 PRODUCT PORTFOLIO 418
16.1.4 RECENT DEVELOPMENTS 419
16.2 ANTECH DIAGNOSTICS, INC 421
16.2.1 COMPANY SNAPSHOT 421
16.2.2 PRODUCT PORTFOLIO 421
16.2.3 RECENT DEVELOPMENT 422
16.3 VIRBAC 423
16.3.1 COMPANY SNAPSHOT 423
16.3.2 REVENUE ANALYSIS 424
16.3.3 PRODUCT PORTFOLIO 424
16.3.4 RECENT DEVELOPMENTS 427
16.4 ZOETIS SERVICES LLC 428
16.4.1 COMPANY SNAPSHOT 428
16.4.2 REVENUE ANALYSIS 429
16.4.3 PRODUCT PORTFOLIO 429
16.4.4 RECENT DEVELOPMENTS 430
16.5 THERMO FISHER SCIENTIFIC INC. 432
16.5.1 COMPANY SNAPSHOTS 432
16.5.2 REVENUE ANALYSIS 433
16.5.3 PRODUCT PORTFOLIO 433
16.5.4 RECENT DEVELOPMENT 434
16.6 ALVEDIA 435
16.6.1 COMPANY SNAPSHOT 435
16.6.2 PRODUCT PORTFOLIO 435
16.6.3 RECENT DEVELOPMENT 437
16.7 AGROLABO S.P.A. 438
16.7.1 COMPANY SNAPSHOT 438
16.7.2 PRODUCT PORTFOLIO 438
16.7.3 RECENT DEVELOPMENT 439
16.8 ADVACARE PHARMA 440
16.8.1 COMPANY SNAPSHOT 440
16.8.2 PRODUCT PORTFOLIO 440
16.8.3 RECENT DEVELOPMENT 441
16.9 BIOMÉRIEUX 442
16.9.1 COMPANY SNAPSHOTS 442
16.9.2 REVENUE ANALYSIS 442
16.9.3 PRODUCT PORTFOLIO 443
16.9.4 RECENT DEVELOPMENT 443
16.10 BIONOTE USA INC. 444
16.10.1 COMPANY SNAPSHOT 444
16.10.2 PRODUCT PORTFOLIO 444
16.10.3 RECENT DEVELOPMENTS 446
16.11 BIO-RAD LABORATORIES, INC. 447
16.11.1 COMPANY SNAPSHOT 447
16.11.2 REVENUE ANALYSIS 447
16.11.3 PRODUCT PORTFOLIO 448
16.11.4 RECENT DEVELOPMENT 449
16.12 ESAOTE SPA 450
16.12.1 COMPANY SNAPSHOT 450
16.12.2 PRODUCT PORTFOLIO 450
16.12.3 RECENT DEVELOPMENTS 451
16.13 EIKEN CHEMICAL CO., LTD. 452
16.13.1 COMPANY SNAPSHOTS 452
16.13.2 REVENUE ANALYSIS 452
16.13.3 PRODUCT PORTFOLIO 453
16.13.4 RECENT DEVELOPMENT 453
16.14 FUJIFILM HOLDINGS CORPORATION 454
16.14.1 COMPANY SNAPSHOT 454
16.14.2 REVENUE ANALYSIS 454
16.14.3 PRODUCT PORTFOLIO 455
16.14.4 RECENT DEVELOPMENT 457
16.15 GOLD STANDARD DIAGNOSTICS 458
16.15.1 COMPANY SNAPSHOT 458
16.15.2 PRODUCT PORTFOLIO 458
16.15.3 RECENT DEVELOPMENT 459
16.16 HANGZHOU ANTIGENNE TECHNOLOGY CO., LTD. 460
16.16.1 COMPANY SNAPSHOT 460
16.16.2 PRODUCT PORTFOLIO 460
16.16.3 RECENT DEVELOPMENT 464
16.17 HIMEDIA LABORATORIES 465
16.17.1 COMPANY SNAPSHOT 465
16.17.2 PRODUCT PORTFOLIO 465
16.17.3 RECENT DEVELOPMENT 467
16.18 INNOVATIVE DIAGNOSTICS 468
16.18.1 COMPANY SNAPSHOT 468
16.18.2 PRODUCT PORTFOLIO 468
16.18.3 RECENT DEVELOPMENT 471
16.19 KH MEDICAL 472
16.19.1 COMPANY SNAPSHOT 472
16.19.2 PRODUCT PORTFOLIO 472
16.19.3 RECENT DEVELOPMENT 473
16.20 MYLAB DISCOVERY SOLUTIONS PVT. LTD. 474
16.20.1 COMPANY SNAPSHOT 474
16.20.2 PRODUCT PORTFOLIO 474
16.20.3 RECENT DEVELOPMENT 475
16.21 MERIDIAN BIOSCIENCE, INC. 476
16.21.1 COMPANY SNAPSHOT 476
16.21.2 PRODUCT PORTFOLIO 476
16.21.3 RECENT DEVELOPMENT 478
16.22 NOVA BIOMEDICAL 479
16.22.1 COMPANY SNAPSHOT 479
16.22.2 PRODUCT PORTFOLIO 479
16.22.3 RECENT DEVELOPMENT 481
 
16.23 NARANG MEDICAL LIMITED 482
16.23.1 COMPANY SNAPSHOT 482
16.23.2 PRODUCT PORTFOLIO 482
16.23.3 RECENT DEVELOPMENT 484
16.24 NEOGEN CORPORATION 485
16.24.1 COMPANY SNAPSHOT 485
16.24.2 REVENUE ANALYSIS 485
16.24.3 PRODUCT PORTFOLIO 486
16.24.4 RECENT DEVELOPMENTS 486
16.25 PLANMECA OY 487
16.25.1 COMPANY SNAPSHOT 487
16.25.2 PRODUCT PORTFOLIO 487
16.25.3 RECENT DEVELOPMENT 487
16.26 QIAGEN 488
16.26.1 COMPANY SNAPSHOT 488
16.26.2 REVENUE ANALYSIS 488
16.26.3 PRODUCT PORTFOLIO 489
16.26.4 RECENT DEVELOPMENTS/NEWS 489
16.27 RANDOX LABORATORIES LTD. 490
16.27.1 COMPANY SNAPSHOT 490
16.27.2 PRODUCT PORTFOLIO 490
16.27.3 RECENT DEVELOPMENT 491
16.28 RING BIOTECHNOLOGY CO LTD. 492
16.28.1 COMPANY SNAPSHOT 492
16.28.2 PRODUCT PORTFOLIO 492
16.28.3 RECENT DEVELOPMENT 493
16.29 SYSMEX CORPORATION 494
16.29.1 COMPANY SNAPSHOTS 494
16.29.2 REVENUE ANALYSIS 494
16.29.3 PRODUCT PORTFOLIO 495
16.29.4 RECENT DEVELOPMENT 495
16.30 SKYLA CORPORATION 496
16.30.1 COMPANY SNAPSHOT 496
16.30.2 PRODUCT PORTFOLIO 496
16.30.3 RECENT DEVELOPMENT 497
16.31 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD. 498
16.31.1 COMPANY SNAPSHOT 498
16.31.2 PRODUCT PORTFOLIO 498
16.31.3 RECENT DEVELOPMENT 499
 
16.32 URIT MEDICAL ELECTRONIC CO., LTD. 500
16.32.1 COMPANY SNAPSHOT 500
16.32.2 PRODUCT PORTFOLIO 500
16.32.3 RECENT DEVELOPMENT 504
16.33 VETDIAG GENOMIX PVT LTD 505
16.33.1 COMPANY SNAPSHOT 505
16.33.2 PRODUCT PORTFOLIO 505
16.33.3 RECENT DEVELOPMENT 506
16.34 VMRD, INC. 507
16.34.1 COMPANY SNAPSHOT 507
16.34.2 PRODUCT PORTFOLIO 507
16.34.3 RECENT DEVELOPMENT 507
17 QUESTIONNAIRE 508
18 RELATED REPORTS 513